Regeneron, San Diego-based biotech company Illumina and 17 health systems invested in the $320 million round. Regeneron ...
Funded by the National Human Genome Research Institute (NHGRI) of the National Institutes of Health (NIH), the project aims to accurately reflect the full range of human diversity worldwide ...
spokesman for the US National Human Genome Research Institute (NHGRI), told The Scientist. He added: "The announcement of Affymetrix's new chip appears to be an important step toward that ... Experts ...
Researchers hope the AI tool will aid in the development of cell-specific gene therapies to treat diseases such as cancer.
The microplate reader market is projected to grow from USD 605.2 million in 2023 to USD 916.8 million by 2031, driven by ...
Personalized organoids — ‘mini-organs’ — may accelerate treatment for patients with rare genetic disorders. Courtesy of Europeana via Unsplash Across the globe, countless babies ...
The most complex engineering of human cell lines ever has been achieved by scientists, revealing that our genomes are more ...